Genotype specific therapies for cystic fibrosis

E. Kerem (Jerusalem, Israel)

Source: Annual Congress 2004 - New approaches to cystic fibrosis: from cells and molecules to novel therapies
Session: New approaches to cystic fibrosis: from cells and molecules to novel therapies
Session type: Assembly Symposium
Number: 4026

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Kerem (Jerusalem, Israel). Genotype specific therapies for cystic fibrosis. Annual Congress 2004 - New approaches to cystic fibrosis: from cells and molecules to novel therapies

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genotype-specific small-molecule therapy for cystic fibrosis
Source: Breathe 2013; 9: 176-186
Year: 2013


Cystic fibrosis: prospects for therapy of some class 1 mutations
Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver?
Year: 2007


Targeting CFTR as a therapy for cystic fibrosis
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

Novel therapeutics for cystic fibrosis
Source: ERS Webinar 2020: Novel therapeutics for cystic fibrosis
Year: 2020


Update on new treatments for cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020


Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles
Source: ERJ Open Res, 5 (2) 00082-2019; 10.1183/23120541.00082-2019
Year: 2019



Genomically-guided therapies: a new era for cystic fibrosis
Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Year: 2020


Genotype and progressive lung damage in adult cystic fibrosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 502s
Year: 2003

Emerging pathogens in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66
Year: 2006

Neomacrolides in cystic fibrosis
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012


New cystic fibrosis therapy targets
Source: Research Seminar 2014 - Protein quality control in lung disease
Year: 2014

The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Comorbidities in cystic fibrosis
Source: International Congress 2015 – Comorbidities in COPD and other chronic lung diseases
Year: 2015



Antibiotic treatment of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 188-202
Year: 2014


How much genotype influences cystic fibrosis associated liver disease?
Source: Eur Respir J 2006; 28: Suppl. 50, 717s
Year: 2006

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021
Year: 2021